Champions Oncology (CSBR) Current Assets (2011 - 2026)
Champions Oncology (CSBR) posted quarterly Current Assets of $19.2 million for Q2 2026, down 14.04% year-over-year from $22.4 million in Q2 2025, and down 4.79% quarter-over-quarter from $20.2 million in Q1 2026.
Champions Oncology (CSBR) Current Assets (2011 - 2026) Analysis & Trends
Champions Oncology's Current Assets history runs 16 years deep, the most recent figure standing at $19.2 million for Q2 2026.
- In Q2 2026, Current Assets fell 14.04% year-over-year to $19.2 million; the TTM figure through Apr 2026 stood at $19.2 million (down 14.04% YoY), while the FY2026 annual figure was $19.2 million, down 14.04% from the prior year.
- Current Assets for Q2 2026 stood at $19.2 million, down from $20.2 million in the prior quarter.
- The five-year high for Current Assets was $22.4 million in Q2 2025, with the low at $13.2 million in Q3 2024.
- The 5-year median for Current Assets is $19.3 million (2023), against an average of $18.0 million.
- The sharpest annual moves came in 2024 and 2025: Current Assets plunged 35.17% in 2024, then jumped 63.93% in 2025.
- Champions Oncology's Current Assets stood at $20.6 million in 2022, then slumped by 31.98% to $14.0 million in 2023, then advanced by 0.48% to $14.1 million in 2024, then surged by 51.46% to $21.3 million in 2025, then decreased by 9.91% to $19.2 million in 2026.
- Business Quant data shows CSBR's Current Assets at $19.2 million in Q2 2026, $20.2 million in Q1 2026, and $21.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 1.76 Bn |
| 10 | Champions Oncology | 72.48 Mn | 72.48 Mn | 7.03 Mn | 19.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 19.22 Mn |
| Jan 31, 2026 | 20.19 Mn |
| Oct 31, 2025 | 21.33 Mn |
| Jul 31, 2025 | 21.01 Mn |
| Apr 30, 2025 | 22.36 Mn |
| Jan 31, 2025 | 19.70 Mn |
| Oct 31, 2024 | 14.08 Mn |
| Jul 31, 2024 | 13.18 Mn |
| Apr 30, 2024 | 13.64 Mn |
| Jan 31, 2024 | 13.20 Mn |
| Oct 31, 2023 | 14.02 Mn |
| Jul 31, 2023 | 14.92 Mn |
| Apr 30, 2023 | 19.46 Mn |
| Jan 31, 2023 | 20.36 Mn |
| Oct 31, 2022 | 20.61 Mn |
| Jul 31, 2022 | 18.37 Mn |
| Apr 30, 2022 | 19.66 Mn |
| Jan 31, 2022 | 17.83 Mn |
| Oct 31, 2021 | 13.70 Mn |
| Jul 31, 2021 | 12.60 Mn |